Literature DB >> 12241796

Research ethics committees and public dissemination of clinical trial results.

Howard Mann1.   

Abstract

Biomedical research involving human beings is subject to codes of ethical conduct that mandate review, approval, and monitoring of clinical trials by research ethics committees (RECs). The role of RECs in public dissemination of results of research is not addressed explicitly in international codes or national regulations governing human research. I contend that RECs should have a prominent role in ensuring that trial results are publicly disseminated. I also propose specific responsibilities and actions that should be assumed and implemented by RECs to promote this objective.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2002        PMID: 12241796     DOI: 10.1016/S0140-6736(02)09613-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  [Psychiatrists and the pharmaceutical industry].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

2.  The Olivieri Report--a compelling study of the growing tensions in clinical research.

Authors:  Vincent di Norcia
Journal:  Sci Eng Ethics       Date:  2003-01       Impact factor: 3.525

3.  Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?

Authors:  R Dal-Ré; R Ortega; E Morejón
Journal:  J Med Ethics       Date:  2005-06       Impact factor: 2.903

Review 4.  Research protocols: waiving confidentiality for the greater good.

Authors:  An-Wen Chan; Ross Upshur; Jerome A Singh; Davina Ghersi; François Chapuis; Douglas G Altman
Journal:  BMJ       Date:  2006-05-06

5.  Informing research participants of research results: analysis of Canadian university based research ethics board policies.

Authors:  S D Macneil; C V Fernandez
Journal:  J Med Ethics       Date:  2006-01       Impact factor: 2.903

6.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

7.  Ethical challenges in conducting clinical research in lung cancer.

Authors:  Peter Allmark; Angela M Tod
Journal:  Transl Lung Cancer Res       Date:  2016-06

8.  Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients.

Authors:  Grégoire Moutel; Nathalie Duchange; François Raffi; Lama I Sharara; Ioannis Théodorou; Violaine Noël; Sandrine de Montgolfier; Ingrid Callies; François Bricaire; Christian Hervé; Catherine Leport
Journal:  Eur J Hum Genet       Date:  2005-09       Impact factor: 4.246

9.  Disseminating results: community response and input on Kisumu breastfeeding study.

Authors:  K Ondenge; E McLellan-Lemal; E Awuonda; F Angira; L A Mills; T Thomas
Journal:  Transl Behav Med       Date:  2015-06       Impact factor: 3.046

10.  Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study.

Authors:  Jean-Pierre Quenot; Hervé Mentec; François Feihl; Djillali Annane; Christian Melot; Philippe Vignon; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.